ZDNET's key takeaways AT&T's $177 million settlement is for data breaches in 2019 and 2024.Claim up to $5,000 (first breach) ...
The transition from CSP to KSP has triggered failures in smart card authentication, IIS connectivity, and recovery mode ...
Cosentyx® (secukinumab) achieved statistically significant and clinically meaningful sustained remission vs placebo at Week 521Trial showed reduction in annual cumulative steroid dose vs placebo ...
The decision adds to the Second Circuit’s growing body of law on defamation claims involving rap lyrics, and offers a ...
The RRB NTPC Notification 2025 was released for 5810 vacancies. Apply online between October 21 and November 20 at ...
The Q3 of Insilico Medicine's Pharma.AI Quarterly Launch webinar—titled “Towards Pharmaceutical Superintelligence” —was ...
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...
Recommendation based on TULIP-SC Phase III trial results showing first-in-class Saphnelo reduced disease activity via once-weekly subcutaneous administration AstraZeneca's Saphnelo (anifrolumab) has ...
Introduction Proactive and easily accessible interventions are needed to support people with long-term health conditions who experience limitations in activities of everyday life. However, there is a ...
Stop wasteful giveaways. Learn 8 smart Shopify gift ideas (threshold, tiered, samples, mystery, earned, digital, seasonal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback